Pharmaceutical Logistics Market by Mode of Transportation (Air Shipping, Rail Shipping, Road Shipping), Product (Biologic & Biosimilar, Branded Drugs, Generic Drugs), Transport, Drug Supply Stage - Global Forecast 2024-2030
The Pharmaceutical Logistics Market size was estimated at USD 69.68 billion in 2023 and expected to reach USD 73.12 billion in 2024, at a CAGR 5.28% to reach USD 99.94 billion by 2030.
Pharmaceutical logistics is managing the flow of medicines, drugs, and healthcare products from manufacturers to distributors and ultimately to patients. It involves a series of coordinated activities, including procurement, handling, warehousing, distribution, and transportation, while ensuring the products' integrity, safety, and compliance with regulatory standards. The aim is to deliver the right products in the appropriate condition and quantity to the desired location on time, efficiently, and securely. Meanwhile, the growing need for temperature-controlled logistics for medicine and increased demand for vaccines and drugs worldwide has bolstered the growth of pharmaceutical logistics. However, the concerns associated with the complex process and the stringent government regulations related to pharmaceutical logistics present a significant challenge for companies operating in the global space. Companies are constantly focusing on developing more advanced cold chain solutions, real-time monitoring systems, drone delivery for inaccessible regions, and sustainable packaging solutions to remain agile within the global landscape. Moreover, the integration of blockchain for better traceability, the use of AI and data analytics for predictive logistics, and advancements in temperature-controlled logistics to ensure the efficacy of temperature-sensitive products are advent and present a significant opportunity for the key companies.
Regional Insights
In the Americas, the United States and Canada are significant hubs in pharmaceutical logistics due to their large consumer market, sophisticated healthcare infrastructure, and a strong presence of global pharmaceutical corporations. The increasing demand for personalized medicine and a high chronic disease prevalence rate drive the demand for pharmaceutical logistics solutions in this region. Additionally, emerging markets in Latin America present a varied pharmaceutical logistics landscape, affected by disparate regulatory systems and the need for infrastructure improvements. Similarly, the European Union's pharmaceutical logistics sector is governed by tight regulations, especially concerning drug safety and traceability. Integrated logistics solutions are in demand in this region, bolstered by the high penetration of digital technologies to manage cross-border pharmaceutical flows. On the other hand, The logistics market in the Middle East is experiencing growth through strategic geographic positioning and investments in infrastructure such as air and sea ports. There's a rising demand for high-quality chronic care medications and an increase in private healthcare facilities, requiring prompt and advanced logistics solutions. Moreover, the Asia-Pacific region is experiencing significant growth in the pharmaceutical logistics market, driven by the expanding healthcare sector, advancements in pharmaceutical manufacturing, and the increasing demand for efficient distribution of medical products. Factors such as a swelling patient pool, government initiatives to improve healthcare infrastructure, and a surge in the pharmaceutical industry's focus on emerging markets are key contributors to this growth.
Market Insights
Market Dynamics
The market dynamics represent an ever-changing landscape of the Pharmaceutical Logistics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market Drivers
Growing Demand for the Temperature Controlled Logistics
Potential Need for the Outsourcing of Pharmaceutical Logistic Process
Increase in Global Demand for Vaccines and Drugs
Market Restraints
Concerns Associated with Complex Process and Inefficient Product Labeling
Market Opportunities
Integration of Advanced Technologies in Pharmaceutical Logistics
Ongoing Investments and Expansion of the Pharma Industry
Market Challenges
Stringent Government Regulations for Pharmaceutical Logistics
Market Segmentation Analysis
Mode of Transportation: Growing preference for air and sea shipping due to their better safety controls and reliability
Drug Supply Stage: Utilization of in-house and outsourced management for inventory control as per their need in large and SMEs
Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Pharmaceutical Logistics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Pharmaceutical Logistics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
World Courier Opens Three New US Transport Stations
World Courier, a Cencora subsidiary, expands its operational footprint within the United States by inaugurating new transport hubs in Denver, Indianapolis, and San Diego. These strategic expansions are expected to significantly enhance the company's ability to manage and deliver complex specialty pharmaceuticals requiring stringent handling procedures, including cryogenic storage. This expansion underscores World Courier's dedication to meeting the intricate logistics demands of the specialty pharmaceutical sector, providing an advanced infrastructure poised to streamline the safe and efficient distribution of these vital healthcare products.
SkyCell and Delta Cargo Forge Strategic Partnership
Delta Cargo entered into a partnership with SkyCell to redefine pharmaceutical logistics. This strategic partnership leverages Delta Cargo's extensive global network, offering unparalleled reach to hundreds of locales while managing vast quantities of cargo transport annually. Incorporating SkyCell's revolutionary hybrid containers into Delta Cargo's lineup is a leap forward in the seamless and safe transport of pharmaceutical products. This integration signifies a milestone in enhancing specialized shipping services for the healthcare sector.
Pharma.Aero Launches Project to Improve Pharmaceutical Supply Chains
Pharma.Aero, a non-profit entity dedicated to strengthening connections between life sciences and medical technology producers and the global industry, launched the Green Air Pharma Logistics Project, emphasizing developing a green lane. This progressive venture, guided by the expertise of Changi Airport Group and with strategic input from Brussels Airport Company executives, aims to propel pharmaceutical manufacturers forward on the path to sustainability.
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Pharmaceutical Logistics Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Pharmaceutical Logistics Market, highlighting leading vendors and their innovative profiles. These include A.P. Møller – Mærsk A/S, Air Canada, AIT Worldwide Logistics, Inc., Almac Group, AmerisourceBergen Corporation, AWL India Private Limited, Bilcare Limited, C.H. Robinson Worldwide, Inc., Catalent, Inc., CEVA Logistics, Clinigen Group PLC, Crown LSP Group, DHL International GmbH by Deutsche Post AG, DSV A/S, FedEx Corporation, ICON PLC, Infosys Limited, Kerry Logistics Network Limited, Kuehne + Nagel International AG, Lineage, Inc., Lonza Group Ltd., Movianto Group, NextPharma Logistics GmbH, Nippon Express Co., Ltd., Parexel International Corporation, SEKO Logistics, SF Express Co., Ltd., Thermo Fisher Scientific, Inc., United Parcel Service of America, Inc., and YUSEN LOGISTICS CO., LTD..
Market Segmentation & Coverage
This research report categorizes the Pharmaceutical Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:
Mode of Transportation
Air Shipping
Rail Shipping
Road Shipping
Sea Shipping
Product
Biologic & Biosimilar
Branded Drugs
Generic Drugs
Transport
Cold-chain Transport
Non Cold-chain Transport
Drug Supply Stage
In-house
Outsourced
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Demand for the Temperature Controlled Logistics
5.1.1.2. Potential Need for the Outsourcing of Pharmaceutical Logistic Process
5.1.1.3. Increase in Global Demand for Vaccines and Drugs
5.1.2. Restraints
5.1.2.1. Concerns Associated with Complex Process and Inefficient Product Labeling
5.1.3. Opportunities
5.1.3.1. Integration of Advanced Technologies in Pharmaceutical Logistics
5.1.3.2. Ongoing Investments and Expansion of the Pharma Industry
5.1.4. Challenges
5.1.4.1. Stringent Government Regulations for Pharmaceutical Logistics
5.2. Market Segmentation Analysis
5.2.1. Mode of Transportation: Growing preference for air and sea shipping due to their better safety controls and reliability
5.2.2. Drug Supply Stage: Utilization of in-house and outsourced management for inventory control as per their need in large and SMEs
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
5.9.1. Value-Chain Analaysis
6. Pharmaceutical Logistics Market, by Mode of Transportation
6.1. Introduction
6.2. Air Shipping
6.3. Rail Shipping
6.4. Road Shipping
6.5. Sea Shipping
7. Pharmaceutical Logistics Market, by Product
7.1. Introduction
7.2. Biologic & Biosimilar
7.3. Branded Drugs
7.4. Generic Drugs
8. Pharmaceutical Logistics Market, by Transport
8.1. Introduction
8.2. Cold-chain Transport
8.3. Non Cold-chain Transport
9. Pharmaceutical Logistics Market, by Drug Supply Stage
9.1. Introduction
9.2. In-house
9.3. Outsourced
10. Americas Pharmaceutical Logistics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Pharmaceutical Logistics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Pharmaceutical Logistics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. World Courier Opens Three New US Transport Stations
13.3.2. SkyCell and Delta Cargo Forge Strategic Partnership
13.3.3. Pharma.Aero Launches Project to Improve Pharmaceutical Supply Chains